Gastrointestinal stromal tumors (GIST): a proposal of a “CT-based predictive model of Miettinen index” in predicting the risk of malignancy
Sign Up to like & getrecommendations! Published in 2019 at "Abdominal Radiology"
DOI: 10.1007/s00261-019-02209-7
Abstract: To identify the predictors of malignancy on CT for the evaluation of gastrointestinal stromal tumors (GIST) by correlating CT findings with the mitotic index in order to propose a “CT-based predictive model of Miettinen index.”… read more here.
Keywords: index; radiology; gastrointestinal stromal; stromal tumors ... See more keywords
Quality of life and performance capacity in patients with breast cancer and patients with gastro-intestinal stromal tumors (GIST).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18881
Abstract: e18881Background: Breast cancer is the most common among argentine women. In contrast, gastrointestinal stromal tumors (GIST) are infrequent neoplasms, with a similar incidence for both sexes. The ... read more here.
Keywords: breast cancer; life performance; stromal tumors; tumors gist ... See more keywords
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e23521
Abstract: e23521 Background: Regorafenib (REG) is a multikinase inhibitor approved as third-line treatment in gastrointestinal stromal tumors (GIST). Although its proven activity, REG can present a relevant adverse profile which often leads to treatment modifications and… read more here.
Keywords: stromal tumors; treatment; tumors gist; schedule ... See more keywords